Dilution Risk from the Exercise of Stock Acquisition Rights
First written in FY2022. 7 of 10 entries say "Materialised", first in FY2023-Q2. Latest entry: FY2026-H1.
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
- FY2026-H1MaterialisedAnnual report
「1 January 2026–30 June 2026 (Note) 480 12,265,280 1 50,012 1 12 (Note) Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in 480 shares being issued in the first half of 2026, further realizing potential dilution. - FY2025MaterialisedAnnual report
「The increase of 4,560 in the total number of issued common shares was due to the exercise of stock options.」
The exercise of stock acquisition rights resulted in 4,560 shares being issued in 2025, further realizing potential dilution. - FY2025-H1MaterialisedAnnual report
「1 January 2025–31 May 2025 (Note) 1 880 12,261,120 1 June 2025–30 June 2025 (Note) 1 2,700 12,263,820 (Note) 1. Exercise of stock acquisition rights」
Exercise of stock acquisition rights resulted in a total of 3,580 shares being issued in the first half of 2025, further realizing potential dilution. - FY2024-H1MaterialisedAnnual report
「1 January 2024–25 June 2024 (Note) 1 71,220 10,430,380 181 557,839 181 1,201,110 (Note) 1. Exercise of stock acquisition rights」
The exercise of stock acquisition rights resulted in the issuance of 71,220 shares from January through 25 June 2024, further realizing potential dilution. - FY2024-Q1MaterialisedAnnual report
「1 January 2024–31 March 2024 (Note) 36,500 10,395,660 93 557,750 93 1,201,021 (Note) Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in the issuance of 36,500 shares from January through March 2024, further realizing potential dilution. - FY2023MitigatedAnnual report
「As of the end of the fiscal year, the number of potential shares underlying these stock acquisition rights was 387,180, equivalent to 3.60% of the total of 10,746,340 issued shares and potential shares.」
Potential shares underlying stock acquisition rights declined to 387,180, or 3.60% of issued shares plus potential shares, from 10.95% in fiscal 2022. Meanwhile, 435,940 shares were exercised during 2023, resulting in actual dilution. - FY2023-Q3MaterialisedAnnual report
「1 July 2023–30 September 2023 (Note) 2,240 10,356,340 5 557,650 5 1,200,921 (Note) Increase due to the exercise of stock acquisition rights.」
Shares were issued through exercise during the quarter, increasing shares outstanding by 2,240 and further realizing part of the potential dilution. - FY2023-Q3RestatedAnnual report
「There were no new business risks or material changes to the business risks described in the annual securities report for the prior fiscal year during the cumulative third-quarter period.」
No new business risks or material changes to existing risks were reported. - FY2023-Q2MaterialisedAnnual report
「186,920 10,354,100 43,580 557,644 43,824 1,200,915 (Note) Increase due to the exercise of stock acquisition rights.」
Shares were actually issued through exercise of stock acquisition rights, increasing shares outstanding by 186,920 from April through June 2023 and partially realizing potential dilution. - FY2022First statedAnnual report
「As of the end of the fiscal year, the number of potential shares underlying these stock acquisition rights was 997,120, equivalent to 10.95% of the total of 10,920,340 issued shares and potential shares.」
The 997,120 potential shares underlying stock acquisition rights represented 10.95% of issued shares plus potential shares, indicating possible dilution upon exercise.